Skip to main content

and
  1. Article

    Open Access

    Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study

    To compare the adverse events after initiation of nevirapine-based ART among HIV-infected patients who did not receive fluconazole (group A), received fluconazole 400 mg/week (group B), and received fluconazol...

    Weerawat Manosuthi, Nopphanath Chumpathat, Achara Chaovavanich in BMC Infectious Diseases (2005)

  2. Article

    Open Access

    Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole

    The clinical data of plasma NVP level, safety and efficacy of antiretroviral therapy (ART) for the concurrent use of nevirapine (NVP)-based ART and fluconazole (FLU) is scanty.

    Weerawat Manosuthi, Chatiya Athichathanabadi in BMC Infectious Diseases (2007)

  3. Article

    Open Access

    Durability of Stavudine, Lamivudine and Nevirapine among Advanced HIV-1 Infected Patients with/without Prior Co-administration of Rifampicin: A 144-week Prospective Study

    To date, data on the durability of a regimen of stavudine, lamivudine and nevirapine are very limited, particularly from the resource-limited settings.

    Weerawat Manosuthi, Preecha Tantanathip, Wisit Prasithisirikul in BMC Infectious Diseases (2008)

  4. Article

    Open Access

    Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database

    To assess the risk and the prognostic significance of tuberculosis (TB) diagnosis in patients from The TREAT Asia HIV Observational Database, a multi-centre prospective cohort of HIV-infected patients receivin...

    Jialun Zhou, Julian Elliott, Patrick CK Li, Poh Lian Lim in BMC Infectious Diseases (2009)